RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      저등급 표재성 방광암의 재발에서 Matrix Metalloproteinase 발현의 분석 = Analysis of Matrix Metalloproteinase Expression in the Recurrence of Superficial Low Grade Urothelial Bladder Cancer

      한글로보기

      https://www.riss.kr/link?id=A104590762

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Superficial bladder transitional cell carcinomas(TCCa) have high recurrence rates following endoscopic resection. Most of the parameters used for the prediction of a recurrence are associated with high grade TCCa. However, there are few valid...

      Purpose: Superficial bladder transitional cell carcinomas(TCCa) have high recurrence rates following endoscopic resection. Most of the parameters used for the prediction of a recurrence are associated with high grade TCCa. However, there are few valid parameters for prediction of the recurrence of low grade TCCa. We aimed to elucidate the prime factor of a recurrence of superficial low grade bladder TCCa.
      Materials and Methods: Thirty cases of superficial low grade bladder TCCa were analyzed, 15 of which were recurred cases. Fresh frozen tumor and normal tissues were used for the analysis. Real-time reverse transcriptase polymerase chain reaction(RT-PCR) and Western blots analyses were subsequently performed to evaluate the validity of the molecules identified by a 0.12K cDNA array, including matrix metalloproteinase (MMP), oncogenes and cell-cycle-related genes.
      Results: On cDNA microarray analysis, MMP-1, 2, 9, 12 and 15, and transforming growth factor β1(TGFβ1), vascular endothelial growth factor(VEGF) and fos were found to be significantly upregulated in the recurred cases. From the real-time RT-PCR for the validation of those molecules, MMP-1 and 12, and TGFβ1, VEGF and fos were significantly overexpressed in the recurred cases. Western blot showed significant overexpression of MMP-1 and 12, and TGFβ1, VEGF and fos in the recurred cases.
      Conclusions: The overexpressions of MMP-1 and 12, and TGFβ1, VEGF and fos may be associated with the recurrence of superficial low grade bladder TCCa.

      더보기

      참고문헌 (Reference)

      1 "Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera" 90 : 1414-1421, 2004

      2 "Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins,c-Jun and p300" 553 : 104-108, 2003

      3 "Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers:role of vascular endothelial growth factor" 171 : 4340-4351, 2003

      4 "Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription" 20 : 5715-5724, 2001

      5 "Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells" 17 : 27-34, 1999

      6 "Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas" 9 : 5573-5581, 2003

      7 "The role of angiostatin,vascular endothelial growth factor,matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma" 10 : 62-72, 2004

      8 "The regulation of neovascularization by matrix metalloproteinases and their inhibitors" 15 : 180-189, 1997

      9 "Stromal expression of invasion-promoting,matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers" 107 : 183-188, 2003

      10 "Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in the recurrence of superficial transitional cell carcinoma of the bladder" 165 : 1769-1772, 2001

      1 "Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera" 90 : 1414-1421, 2004

      2 "Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins,c-Jun and p300" 553 : 104-108, 2003

      3 "Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers:role of vascular endothelial growth factor" 171 : 4340-4351, 2003

      4 "Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription" 20 : 5715-5724, 2001

      5 "Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells" 17 : 27-34, 1999

      6 "Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas" 9 : 5573-5581, 2003

      7 "The role of angiostatin,vascular endothelial growth factor,matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma" 10 : 62-72, 2004

      8 "The regulation of neovascularization by matrix metalloproteinases and their inhibitors" 15 : 180-189, 1997

      9 "Stromal expression of invasion-promoting,matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers" 107 : 183-188, 2003

      10 "Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in the recurrence of superficial transitional cell carcinoma of the bladder" 165 : 1769-1772, 2001

      11 "Significance of MMP-2 expression in prostate cancer:an immunohistochemical study" 63 : 8511-8515, 2003

      12 "Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma" 743-745, 2002

      13 "Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer" 20 : 2009-2013, 2000

      14 "Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder" 7 : 3450-3456, 2001

      15 "Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome." 198 : 258-269, 2002

      16 "Matrix metalloproteinases:molecular aspects of their roles in tumour invasion and metastasis" 36 : 1621-1630, 2000

      17 "Matrix metalloproteinases:a multifunctional group of molecules" 195 : 135-137, 2001

      18 "Matrix metalloproteinases generate angiostatin:effects on neovascularization" 161 : 6845-6852, 1998

      19 "MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer:a comparison with clinicopathologic features and survival" 9 : 130-137, 2001

      20 "Identification of potential biomarkers of lymph node meta-stasis in oral squamous cell carcinoma by cDNA microarray analysis" 106 : 683-689, 2003

      21 "H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras induced invasive phenotype." 85 : 176-181, 2000

      22 "Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder" 10 : 345-349, 2003

      23 "Expression of human macrophage metalloelastase(MMP-12)by tumor cells in skin cancer" 114 : 1113-1119, 2000

      24 "Expression of gelatinase- A(MMP-2)in human colon cancer and normal colon mucosa" 22 : 383-389, 2001

      25 "Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma" 57 : 675-679, 2001

      26 "Cytokine-regulated expression of collagenase-2(MMP-8)is involved in the progression of ovarian cancer" 39 : 2499-2505, 2003

      27 "Cytokine regulation of metalloproteinase gene expression" 53 : 288-95, 1993

      28 "Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis" 14 : 163-176, 2000

      29 "Alteration in urinary matrix metalloproteinase- 9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer" 9 : 2576-2582, 2003

      30 "Activation mechanisms of matrix metalloproteinases" 378 : 151-160, 1997

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-03-12 학회명변경 한글명 : 대한비뇨기과학회 -> 대한비뇨의학회 KCI등재
      2016-03-04 학술지명변경 외국어명 : 미등록 -> Investigative and Clinical Urology KCI등재
      2016-01-15 학술지명변경 한글명 : Korean Journal of Urology -> Investigative and Clinical Urology KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-02-21 학술지명변경 한글명 : 대한비뇨기과학회지 -> Korean Journal of Urology
      외국어명 : The Korean Journal of Urology -> 미등록
      KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.14 0.14 0.13
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.12 0.314 0.23
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼